Ideaya Biosciences Overview
Ideaya Biosciences Target Price
Analysts' 12-month price predictions for IDYA.
Get informed when a big investor buys or sells
+ FollowShare Price
$36.3
Average Target Price
$58.67
61.6% upside
61.6% upside3 analysts in the last 4 months
High: $65 | Low: $53
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-04-14 | Wedbush | $58 | 59.8% upside |  |
| 2026-04-14 | RBC Capital | $53 | 46% upside | |
| 2026-04-13 | Truist Financial | $65 | 79.1% upside | |
| 2026-02-18 | Wedbush | $52 | 43.3% upside | |
| 2026-01-21 | RBC Capital | $45 | 24% upside | |
| 2026-01-06 | Truist FinancialGregory Renza | $60 | 65.3% upside | |
| 2025-11-24 | Truist Financial | $59 | 62.5% upside | |
| 2025-10-21 | New Street | $30 |  17.4% downside | |
| 2025-10-21 | RBC Capital | $41 | 12.9% upside | |
| 2025-09-17 | Guggenheim | $50 | 37.7% upside | |
| 2025-09-09 | RBC CapitalGregory Renza | $38 | 4.7% upside | |
| 2025-09-08 | OppenheimerMatthew Biegler | $36 | 0.8% downside | |
| 2025-09-04 | JMP Securitieslvan Tuerkcan | $41 | 12.9% upside | |
| 2025-09-04 | Barclays | $40 | 10.2% upside | |
| 2024-11-05 | Leerink PartnersAndrew Berens | $27 | 25.6% downside | |
| 2024-10-24 | UBSDavid Dai | $50 | 37.7% upside | |
| 2024-09-25 | Mizuho SecuritiesGraig Suvannavejh | $55 | 51.5% upside | |
| 2024-09-23 | Goldman SachsCorinne Jenkins | $48 | 32.2% upside | |
| 2024-09-23 | Stifel NicolausBen Burnett | $66 | 81.8% upside | |
| 2024-09-23 | BTIGJustin Zelin | $62 | 70.8% upside | |
| 2024-09-10 | Stifel NicolausBen Burnett | $68 | 87.3% upside | |
| 2024-08-27 | CitigroupYigal Nochomovitz | $58 | 59.8% upside | |
| 2024-08-07 | OppenheimerMatthew Biegler | $53 | 46% upside | |
| 2024-07-10 | RBC CapitalGregory Renza | $61 | 68% upside | |
| 2024-07-08 | Mizuho SecuritiesGraig Suvannavejh | $50 | 37.7% upside | |
| 2024-06-03 | Stifel NicolausBen Burnett | $63 | 73.6% upside | |
| 2022-12-28 | Capital One Financial | $29 | 20.1% downside | |
| 2022-09-13 | Guggenheim | $32 | 11.8% downside | |
| 2022-08-18 | Oppenheimer | $20 | 44.9% downside | |
| 2022-08-16 | Robert W. Baird | $18 | 50.4% downside | |